Login / Signup

Efficacy and Safety of Perioperative Angiotensin II Versus Phenylephrine as a First-Line Continuous Infusion Vasopressor in Kidney Transplant Recipients.

Lyra P BeltranJamie J BenkenJonathan JouEnrico BenedettiHokuto NishiokaEnas AlamreiaRachel M BelcherScott T Benken
Published in: Clinical transplantation (2024)
Among kidney transplant recipients, ATII may be a suitable first-line alternative compared with phenylephrine in the perioperative period for hypotension management with a reduced need for additional vasopressor support. Allograft benefits were observed in patients with prolonged CIT.
Keyphrases
  • angiotensin ii
  • cardiac surgery
  • angiotensin converting enzyme
  • patients undergoing
  • vascular smooth muscle cells
  • low dose
  • acute kidney injury
  • kidney transplantation